Australia's largest stock trading and investment forum Australia's #1 stock forum

BIG

0.00%

$2.22 big un limited

Ann: Trading Halt, page-357

First 357 Last

Share
Profile

Follow
Lumpy Pom

307 Posts.

20/02/18

08:49

Post #: 31176808
Share

Originally posted by xmanrocks ↑

Surely all SHers and the markets would agree that it is important to have been told what % of revenue was sponsored revenue otherwise how can one ascertain the true growth prospects of the company going forward.
It is illogical for those on here who say BIG have a good business model when a portion of their revenue is obtained in a unsustainable way.

What I don't understand given that sponsorship revenue is questionable going forward and to establish a more prudent view of the company why no mention of it in the 1/4ly ANN.
The 1/4 Ann had a heap of information in it....including mentioning cash margins of 46%.
It all makes sense now..........as it is easy to achieve huge cash margins when part of your revenue is from a sponcered source that is paid for in equity.
The sponsorship deal is not a sustainable business practice.

IMHO given sponsorship revenue is a material issue and the fact they have avoided reporting it separately in the latest 1/4ly it could easily be deemed by the markets as fudging the numbers.
I feel sorry for holders cause the market ain't going to like this.
Hopefully the company comes clean and tells the markets what revenue portion is "unsustainable sponsored revenue" in the latest numbers and hopefully that number is not to high.

Expand

See post https://hotcopper.com.au/threads/ann-trading-halt.4026199/page-355?post_id=31176313#.WotF_GLZWEc

It’s a small amount and Getting increasingly small as a proportion of revenue as Big grows

Lumpy

BIG Price at posting: $2.22 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 348 more messages in this thread...

First 357 Last

Add BIG (ASX) to my watchlist

Ann: Trading Halt, page-357

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News